Lecanemab’s PDUFA date for its potential accelerated approval is January 6th. The product could launch after its FDA approval. Now the discussion turns to what price it will be launched at, and whether it will eventually be reimbursed by CMS, the predo…
A wave of Covid outbreaks in mainland China are leading to increased testing of travelers from the country.
Christine Grady, PhD, is the Chief of the Department of Bioethics and Head of the Section on Human Subjects Research at the National Institutes of Health (NIH) Clinical Center.
Mark Cuban’s Cost Plus Drug Company is making waves again, as it steadily raises its profile in the generic drugs sector. With more than 1.5 million customers, the company is fast becoming a major disruptor in generic drug pricing.
According to Statnews, primary care visits are down 10.3% across America when compared to pre-pandemic levels. This means 1 in 10 Americans who usually come to see their primary doctor for a general checkup have not done so since the Covid-19 pandemic …
The biggest health story from 2022 isn’t Covid-19. It isn’t RSV or influenza, either. It isn’t cancer, diabetes, or cardiovascular disease. It’s something that encompasses all these diseases and much more. It’s the troubling decline in U.S. life expect…
It’s that time of year again. New year’s resolutions and predictions for the upcoming year. Here, I give some predictions for the economy, public health, and the biopharmaceutical sector.
Aphantasia is a condition in which a person cannot see or imagine mental images. In other words, when they attempt to imagine or think about something they cannot create an internal mental image or picture. While rare, it provides an intriguing window …
This new version of the Omicron Covid-19 coronavirus may be even more immune evasive than previous versions.
Overall, 2022 was an incredibly busy year for healthcare.
